Join leading cardiology experts Carlos Aguiar and Milind Desai, alongside the witty Rohin Francis, as they delve into the latest advancements in drug treatments for hypertrophic cardiomyopathy. They discuss innovative therapies, including cardiac myosin inhibitors, and evaluate their efficacy and safety. The trio also highlights the healing power of humor in medicine, sharing how laughter can enhance patient communication and reduce anxiety. Plus, dive into the fundamentals of regression analysis in medical research for a comprehensive and entertaining experience!

Cardiologist Carlos Aguiar, spirituality expert Kavitha Chinnaiyan, and renowned cardiologist Francesco Maisano discuss lifetime management of aortic valve stenosis and the impact of spirituality on cardiovascular health. Topics include personalized therapy options, integrating spirituality in patient care, and the use of AI technology for statistical analyses in medicine.

Experts Thomas Achenbach, Carlos Aguiar, Michael Blaha, and Edward Nicol discuss coronary artery calcium scoring and the importance of checklists in medicine and aviation. They also explore how being married reduces cardiovascular mortality, emphasizing teamwork and communication in healthcare.

Leading experts Carlos Aguiar, Arash Haghikia, and Juan Pablo Kaski discuss genetic testing in dilated cardiomyopathy and the link between gut microbiome and heart disease. They emphasize the role of genetic testing for relatives, challenges without family history, and the association of gut microbiome with cardiovascular diseases like atherosclerosis and heart failure.

Experts Carlos Aguiar, Gianfranco Parati, and Julie De Backer discuss hypertension treatment, anticoagulation in pregnancy, and advancements in cardiology. Topics include personalized hypertension treatment, anticoagulation during pregnancy, and the use of ROC curve in medical testing.

Cardiologists Stephan Achenbach, Carlos Aguiar, Michael Boehm, and Lene Holmvang discuss topics like long-term beta blockers post-MI, pros and cons of microaxial pump in cardiogenic shock, patient selection for micro-axial pump, and benign cardiac imaging findings in an informative and engaging manner.

Cardiology experts Carlos Aguiar and Deepak Bhatt discuss omega-3 fatty acids benefits and lead-induced tricuspid regurgitation. They explore TAVI outcomes, heart failure, genetic predispositions, and the impact of EPA on cardiovascular health. Martin Andreas provides insights on tricuspid regurgitation in patients with implanted leads. Mythbusters segment examines the effects of pomegranates on heart health.

ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies MINOCA Long QT Syndrome Statistics Made Easy: subgroup analyses and tests for interaction Host: Rick Grobbee Guests: Carlos Aguiar, Martha Gulati, Dieter Nuyens Want to watch that episode? Go to: https://esc365.escardio.org/event/1149   Disclaimer This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.   Declarations of interests Stephan Achenbach, Rick Grobbee, Martha Gulati, Nicolle Kraenkel and Dieter Nuyens have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Novo Nordisk, Terumo, Medtronic. Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies Microplastics and nanoplastics in atheromas and cardiovascular events Leadless pacemakers Snapshots Host: Rick Grobbee Guests: Stephan Achenbach, Carlos Aguiar, Emanuele Barbato, Haran Burri Want to watch that episode? Go to: https://esc365.escardio.org/event/1148   Disclaimer This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.    Declarations of interests  Stephan Achenbach, Emanuele Barbato, Rick Grobbee and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede. Haran Burri has declared to have potential conflicts of interest to report: institutional research and fellowship support or speaker honoraria from Abbott, Biotronik, Boston Scientific, Medtronic, Microport. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Novo Nordisk, Sanofi. Terumo, Medtronic. Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

Experts in cardiology discuss immune checkpoint inhibitors and their impacts on the heart, the importance of HDL and its therapies for cardiovascular health, and the FBI syndrome. Topics include cardiovascular complications of immune checkpoint inhibitors, strategies to elevate HDL levels, and enhancing HDL carriers. The podcast also covers recent key studies in cardiology.